
-
Smoke-dried bodies could be world's 'oldest mummies': study
-
Afghan gets life in prison for jihadist knife murder in Germany
-
Trump bringing $15 bn lawsuit against New York Times
-
Juan Mata moves to Melbourne from Australian rivals
-
UN investigators say Israel committing 'genocide' in Gaza
-
Israel bombards Gaza City as UN probe accuses it of 'genocide'
-
Rubio asks Qatar to stay as mediator after Israel strike
-
Drug cheats put India Olympic bid and careers at risk
-
East Timor police fire tear gas on second day of car purchase protests
-
Austria hit with fresh spy claims after govt promises law change
-
Floods devastate India's breadbasket of Punjab
-
In mega-city Lagos, 20 million count on just 100 ambulances
-
FBI chief Kash Patel faces Senate panel
-
Trump says bringing $15 bn lawsuit against New York Times
-
Israel sets Gaza 'on fire' as Rubio warns days left for deal
-
Phillies clinch first MLB division by beating Dodgers
-
'Nothing here': Lack of jobs forces young Nepalis abroad
-
Rubio asks Qatar to stay as mediator after Israeli strike
-
Trump set for unprecedented second UK state visit
-
Lower US tariffs on Japan autos kick in
-
Revamped Bayern face early test as Chelsea come to town
-
Papua New Guinea, Australia to vow mutual defence in new treaty
-
Malawi election a battle of two presidents
-
Asian markets rise as traders prepare for expected US rate cut
-
Malawi votes in a rematch between two presidents as economic crisis bites
-
Australia says social media ban will not age test all users
-
Poland's Nawrocki talks drone defence in Paris and Berlin
-
Trump's fossil fuel agenda challenged in youth climate suit
-
PSG fear impact of injuries as they put Champions League title on the line
-
US Senate confirms Trump aide to Fed as politics loom over rate meeting
-
Papua New Guinea, Australia will commit to mutual defence
-
Trash, mulch and security: All jobs for troops in Washington
-
Why Leaders Across Industries Are Trusting and Building Good Driver Mutuality
-
Tocvan Announces Commencement Of Field Work And Airborne Magnetics Survey At Gran Pilar Gold Silver Project; Drilling And Trenching Prep Accelerate Discovery & Pilot Mine Production
-
NFL legend Brady to play in March flag football event at Riyadh
-
Lower US tariffs on Japan autos to take effect Tuesday
-
US strikes second alleged Venezuelan drug boat as tensions mount
-
Protesting Peru residents block trains to Machu Picchu
-
US strikes another alleged Venezuelan drug boat as tensions rise
-
White House vows to take on left-wing 'terror' movement after Kirk killing
-
Brazil's Amazon lost area the size of Spain in 40 years: study
-
US Senate poised to advance Trump aide's appointment at Fed
-
Sri Lanka survive Hong Kong scare for four wicket Asia Cup win
-
Arab, Muslim leaders urge review of Israel ties after Qatar attack
-
Mbappe 'not anxious' over Champions League goal as Bellingham returns
-
Huge pot of Nigerian jollof rice sets Guinness record
-
Heartbreak will help Arsenal's Champions League charge: Arteta
-
Europe stumped by Trump demands over Russia sanctions
-
Cycling fears spread of race-halting protests after Vuelta chaos
-
US, China reach 'framework' deal on TikTok ownership

Abortion pill at the center of a US court battle
A widely used abortion pill is at the center of the latest legal battle in America's ongoing debate over abortion.
The US Supreme Court on Wednesday said that it would weigh in on restrictions imposed by a lower court on the drug mifepristone.
Here is the background on the drug and its use:
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for more than half -- 53 percent -- of the 930,160 abortions documented by the reproductive health research and policy organization in the United States in 2020.
While the number of so-called medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions represented 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
The process in fact involves more than one pill. The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000 for use up to seven weeks of pregnancy.
It was later approved for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through other means, such as vacuum aspiration.
The average cost of a medication abortion at Planned Parenthood is $580 but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consult, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and occur when a fertilized egg grows outside the uterus.
- Where is the pill available? -
Around 20 US states have banned or severely restricted access to abortions, including medication abortions, since the Supreme Court's ruling in June 2022 overturning the constitutional right to the procedure.
But anti-abortion groups are seeking to restrict access to mifepristone nationwide, including in states where abortion has remained legal.
The case before the Supreme Court concerns limiting the use of mifepristone to the first seven weeks of pregnancy, instead of 10, and blocking it from being distributed by mail.
O.Johnson--AMWN